Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate® System: three- and six-month endpoint results from the FAST-EU study

This was a prospective, longitudinal, multicenter, single-arm controlled trial, using independent core laboratory validation of MRI results, to establish the effectiveness and confirm the safety of the VizAblate® System in the treatment of symptomatic uterine fibroids. The VizAblate System is a tran...

Descripción completa

Detalles Bibliográficos
Autores principales: Bongers, Marlies, Brölmann, Hans, Gupta, Janesh, Garza-Leal, José Gerardo, Toub, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349947/
https://www.ncbi.nlm.nih.gov/pubmed/25774122
http://dx.doi.org/10.1007/s10397-014-0873-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349947/
https://www.ncbi.nlm.nih.gov/pubmed/25774122
http://dx.doi.org/10.1007/s10397-014-0873-1

Ejemplares similares